Stock Report

Novartis India Limited Q4 FY2023-24 net profit lower at Rs. 14.68 crores

Posted On : 2024-05-11 09:27:34( TIMEZONE : IST )

Novartis India Limited has reported Standalone financial results for the period ended March 31, 2024.

Financial Results (Q4 FY2024) - QoQ Comparison

The company has reported total income of Rs. 91.59 crores during the period ended March 31, 2024 as compared to Rs. 106.50 crores during the period ended December 31, 2023.

The company has posted net profit / (loss) of Rs. 14.68 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 26.57 crores for the period ended December 31, 2023.

The company has reported EPS of Rs. 5.95 for the period ended March 31, 2024 as compared to Rs. 10.76 for the period ended December 31, 2023.

Financials	Q4 FY2024	Q3 FY2024	% Change
Total Income	₹ 91.59 crs	₹106.50 crs	-14.00%
Net Profit	₹14.68 crs	₹26.57 crs	-44.75%
EPS	₹5.95	₹10.76	-44.70%

Financial Results (Q4 FY2024) - YoY Comparison

The company has reported total income of Rs. 91.59 crores during the period ended March 31, 2024 as compared to Rs.92.50 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs.14.68 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.25.02 crores for the period ended March 31, 2023.

The company has reported EPS of Rs.5.95 for the period ended March 31, 2024 as compared to Rs.10.13 for the period ended March 31, 2023.

Financials	Q4 FY2024	Q4 FY2023	% Change
Total Income	₹ 91.59 crs	₹92.50 crs	-0.98%
Net Profit	₹14.68 crs	₹25.02 crs	-41.33%
EPS	₹5.95	₹10.13	-41.26%

Financial Results (Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.396.75 crores during the Financial Year ended March 31, 2024 as compared to Rs.436.85 crores during the Financial Year ended March 31, 2023.

The company has posted net profit / (loss) of Rs.85.19 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.103.36 crores for the Financial Year ended March 31, 2023.

The company has reported EPS of Rs.34.50 for the Financial Year ended March 31, 2024 as compared to Rs.41.86 for the Financial Year ended March 31, 2023.

Financials	Year Ended FY2024	Year Ended FY2023	% Change
Total Income	₹396.75 crs	₹436.85 crs	-9.18%
Net Profit	₹85.19 crs	₹103.36 crs	-17.58%
EPS	₹34.50	₹41.86	-17.58%

Shares of Novartis India Limited was last trading in BSE at Rs. 1069.00 as compared to the previous close of Rs. 1065.55. The total number of shares traded during the day was 9146 in over 444 trades.

The stock hit an intraday high of Rs. 1079.80 and intraday low of 1050.05. The net turnover during the day was Rs. 9753306.00.